Sonex Health has claimed a co-marketing agreement with Samsung NeuroLogica Corporation, the healthcare subsidiary of Samsung Electronics Co., Ltd. This relationship will position Sonex Health and Samsung NeuroLogica as leaders in ultrasound-guided micro-invasive procedures.
Under this agreement, the two companies will promote the importance of using high-quality ultrasound imaging during micro-invasive procedures to optimize outcomes, enhance the patient experience and drive practice efficiencies.
Philip Sullivan, President and Chief Executive Officer of Samsung NeuroLogica said “Using our exquisite image quality in combination with Sonex Health’s elegant techniques to reduce surgical trauma, we can impact the lives of those who suffer debilitating pain and get them relief much faster.”
The SX-One MicroKnife enables micro-invasive carpal tunnel release (CTR) through a micro-incision that is up to five times smaller than the incision made during traditional CTR surgeries—an incision so small, it can be closed with an adhesive bandage or strip. High-quality musculoskeletal ultrasound imaging is a key component for this procedure.